Drugs Made In America Acquisition DMII
NASDAQ DMII
$10.24 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Drugs Made In America Acquisition (DMII) Non Operating Income (2025 - 2026)

Updated

Drugs Made In America Acquisition's Non Operating Income came in at $4.51 million for Q2 2026, up 0.9% from the prior quarter.

Analysis

Drugs Made In America Acquisition (DMII) Non Operating Income (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Drugs Made In America Acquisition reported Non Operating Income of $13.65 million; for FY2025, it came in at $4.68 million.

  • The five-year range for quarterly Non Operating Income is $109,355 (Q3 2025) to $4.57 million (Q4 2025).
  • Business Quant data shows DMII's Non Operating Income at $4.47 million (Q1 2026), $4.57 million (Q4 2025) and $109,355 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 BlackRock 189.07 Bn 145.60 Bn - 316.00 Mn
2 Spdr Gold Trust 125.11 Bn -432.90 Bn - -
3 Brookfield 101.47 Bn -96.66 Bn - -
4 Blackstone 91.35 Bn 85.56 Bn - 93.42 Mn
5 Kkr 87.89 Bn 54.59 Bn 1.76 Bn -
6 Brookfield Asset Management 82.34 Bn 77.22 Bn - -
7 Apollo Global Management 72.94 Bn 89.74 Bn 4.14 Bn 4.00 Mn
8 Wheaton Precious Metals 59.70 Bn 59.70 Bn 538.50 Mn -
9 Ares Management 48.49 Bn 47.07 Bn 376.28 Mn -43.24 Mn
10 Drugs Made In America Acquisition 652.29 Mn 651.45 Mn - 4.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.51 Mn
Mar 31, 2026 4.47 Mn
Dec 31, 2025 4.57 Mn
Sep 30, 2025 109,355.00
API Access

Drugs Made In America Acquisition Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=DMII&period=max&api_key=YOUR_API_KEY